Home LiteratureArticle Details
PMID: 41333974 Published · epublish English Journal Article Systematic Review

Genotype-phenotype correlations in PMS2-associated constitutional mismatch repair deficiency: a systematic literature review.

Oncology reviews ·Vol. 19 ·2025-00-00 ·Pages 1679576

Munteanu CV, Lighezan DL, Capcelea A, Chiriță-Emandi A, Trifa AP

Abstract

Constitutional mismatch repair deficiency (CMMRD) is a rare pediatric cancer predisposition syndrome primarily characterised by central nervous system (CNS), gastro-intestinal (GI) tumours and hematological malignancies, along with NF1-like cutaneous features. The PMS2-related subtype (PMS2-CMMRD) is the most common molecular form of CMMRD, exhibiting variable severity and both early and late-onset clinical presentations. Although pathogenic and likely pathogenic PMS2 heterozygous variants are relatively frequent in healthy population, CMMRD incidence is generally rare in humans and genotype-phenotype correlations are still limited. To better characterise PMS2-CMMRD group, we collected clinical cases described in literature, using three alternative methods (VarChat, VarSome and LitVar2), starting from 102 pathogenic/likely pathogenic PMS2 variants (<50 bp) reported in ClinVar by clinical and research laboratories. PMS2-CMMRD cases were split into two distinct groups based on tumour onset age: early (diagnosis under 10 years) and later-onset (diagnosis after 10 years). Significant differences in tumour distribution were observed, with CNS tumours being most prevalent in the early-onset group, while GI tumours were more common in the later-onset group. Six PMS2 variants were associated with either early or later-onset CMMRD. Future validation through larger prospective cohort studies is necessary to confirm our findings and better understand the natural history of PMS2-CMMRD to inform clinical decision-making in PMS2-Lynch syndrome (PMS2-LS).

Keywords
Lynch PMS2 VarChat constitutional mismatch repair deficiency genotype
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Munteanu Cătălin Vasile
Doctoral School, Victor Babeş University of Medicine and Pharmacy, Timişoara, Romania. | Regional Center of Medical Genetics Timiş, Louis Țurcanu Clinical Emergency Hospital for Children, Timişoara, Romania.
Lighezan Diana Luisa
Department of Hematology, Victor Babes University of Medicine and Pharmacy, Timişoara, Romania. | Multidisciplinary Research Center for Malignant Hematological Diseases, Victor Babes University of Medicine and Pharmacy, Timişoara, Romania.
Capcelea Alexandru
Doctoral School, Victor Babeş University of Medicine and Pharmacy, Timişoara, Romania. | Department of Medical Oncology, OncoHelp Oncology Center, Timişoara, Romania.
Chiriță-Emandi Adela
Regional Center of Medical Genetics Timiş, Louis Țurcanu Clinical Emergency Hospital for Children, Timişoara, Romania. | Department of Microscopic Morphology, Genetics Discipline, Victor Babeş University of Medicine and Pharmacy, Timişoara, Romania. | Center for Genomic Medicine, Victor Babeş University of Medicine and Pharmacy, Timişoara, Romania.
Trifa Adrian Pavel
Department of Microscopic Morphology, Genetics Discipline, Victor Babeş University of Medicine and Pharmacy, Timişoara, Romania. | Center of Expertise on Rare Pulmonary Diseases, Victor Babeş Clinical Hospital of Infectious Diseases and Pneumophysiology, Timişoara, Romania. | Breast Cancer Center, The Oncology Institute "Prof. Dr. Ion Chiricuta", Cluj-Napoca, Romania.
Full Text / Full Text
PMC full text available locally, click to read

Loading full text...

Article Info
Journal
Oncology reviews
Abbr.
Oncol Rev
ISSN
1970-5565
Published
2025-00-00
Epub
2025-00-17
Pages
1679576
Language
English
Region
Switzerland
NLM ID
101519906
PMCID
PMC12665659
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com